A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

The U.S. Food and Drug Administration approved donanemab last July, adding a second treatment to the country’s arsenal against early Alzheimer’s. The first approved drug, lecanemab — sold under the ...

A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

Sometimes, the medicines we take to treat everyday health problems can come with hidden side effects. A new study from the ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

Microglia can be engineered to detect disease-specific brain changes – like amyloid plaques in Alzheimer’s disease – and ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...